From the Food and Drug Administration.
Crawford
Lester M
LM
Office of the Commissioner, US Food and Drug Administration, Rockville, MD 20857, USA.
D000818:Animals; D001803:Blood Transfusion / Q000401:mortality; D002243:Carbolines / Q000627:therapeutic use*; D017277:Drug Approval; D005381:Financing, Organized; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D012109:Research Support as Topic; D014183:Transplantation, Heterologous / Q000331:legislation & jurisprudence / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron